Biovalent Pharmaceutical Private Limited

Founded in 2013 and headquartered in Delhi, India.

2013 | West Delhi, Delhi (India) | Inactive
Last Updated: April 18, 2024

Biovalent Pharmaceutical Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 9 Months
  • Last Filing with ROC 31 Mar 2015
  • Revenue Growth 76.59%
  • Profit Growth 111.78%
  • Ebitda -105.48%
  • Net Worth 1.00%
  • Total Assets -12.61%

About Biovalent Pharmaceutical

Biovalent Pharmaceutical Private Limited (BPPL) is Strike Off company established on 09 Apr 2013 with its office registered at West Delhi, Delhi, India and has been running since 11 Year, 9 Months with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 18 Apr 2024.

Company Details

  • Location

    West Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24100DL2013PTC250532

  • Company No.

    250532

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    09 Apr 2013

  • Date of AGM

    24 Sep 2015

  • Date of Balance Sheet

    31 Mar 2015

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

Who are the key members and board of directors at Biovalent Pharmaceutical?

Board Members (2)

Name Designation Appointment Date Status
Neelam Country flag representing In Director 09-Apr-2013 Current
Vishal Ohlan Country flag representing In Additional Director 18-Jul-2014 Current

Financial Performance of Biovalent Pharmaceutical.

Biovalent Pharmaceutical Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 76.59% increase. The company also saw a substantial improvement in profitability, with a 111.78% increase in profit. The company's net worth moved up by a moderate rise of 1%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
76.59%
Revenue from Operations
80.47%
Total Assets
-12.61%
Profit or Loss
111.78%
Net Worth
1.00%
EBITDA
-105.48%

What is the Ownership and Shareholding Structure of Biovalent Pharmaceutical?

In 2016, Biovalent Pharmaceutical had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Biovalent Pharmaceutical?

Unlock and access historical data on people associated with Biovalent Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biovalent Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biovalent Pharmaceutical's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Biovalent Pharmaceutical

Recent activity within the organization

  • Annual General Meeting

    Biovalent Pharmaceutical Private Limited last Annual general meeting of members was held on 24 Sep 2015 as per latest MCA records.

    24 Sep 2015

  • Balance Sheet

    Biovalent Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Delhi.

    31 Mar 2015

  • Director Appointment

    Vishal Ohlan was appointed as a Additional Director was appointed as a Additional Director on 18 Jul 2014 & has been associated with this company since 10 years 6 months .

    18 Jul 2014

  • Director Appointment

    Neelam was appointed as a Director was appointed as a Director on 09 Apr 2013 & has been associated with this company since 11 years 9 months .

    09 Apr 2013

  • Company Incorporation

    Biovalent Pharmaceutical Private Limited was registered on 09 Apr 2013 with Roc Delhi & aged 11 years 9 months as per MCA records.

    09 Apr 2013

Frequently asked questions

  • Biovalent Pharmaceutical Private Limited was incorporated on 09 Apr 2013.

  • The authorized share capital of Biovalent Pharmaceutical Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Biovalent Pharmaceutical Private Limited.

    • Neelam
    • Vishal Ohlan
  • As per Ministry of Corporate Affairs (Mca), the registered address of Biovalent Pharmaceutical Private Limited is H.No 16Qamruddin Nagar, Nangloi, Delhi West Delhi, India, 110041.

  • The corporate identification number (CIN) of Biovalent Pharmaceutical Private Limited is U24100DL2013PTC250532 and the company number is 250532 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2016, the revenue trend for Biovalent Pharmaceutical Private Limited has risen by 76.59%.

  • The financial reports for the fiscal year 2016 indicates that The net worth of Biovalent Pharmaceutical Private Limited has experienced an upsurge of 1.00%.

  • The most recent Balance Sheet for Biovalent Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2015.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors